Antithrombotic selection and risk factor management in ischemic stroke and transient ischemic attack

1Citations
Citations of this article
39Readers
Mendeley users who have this article in their library.

Abstract

In addition to appropriate antithrombotic therapy, the identification and treatment of modifiable ischemic stroke risk factors can reduce the likelihood of recurrent stroke. Neurosurgeons should be knowledgeable of the specific risk factors and general recommendations for ischemic stroke, as they may play a significant role in the management options for patients with intracranial and extracranial atherosclerotic disease. The authors of this article review the indications for and selection of antithrombotics in patients with cerebral ischemia. In addition, the identification and secondary prevention of select risk factors are discussed. © AANS, 2014.

Cite

CITATION STYLE

APA

Katz, B. S., & Flemming, K. D. (2014). Antithrombotic selection and risk factor management in ischemic stroke and transient ischemic attack. Neurosurgical Focus, 36(1). https://doi.org/10.3171/2013.10.FOCUS13402

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free